Alberti, Simon https://orcid.org/0000-0003-4017-6505
Arosio, Paolo https://orcid.org/0000-0002-2740-1205
Best, Robert B. https://orcid.org/0000-0002-7893-3543
Boeynaems, Steven https://orcid.org/0000-0002-9705-9871
Cai, Danfeng https://orcid.org/0000-0003-1623-5077
Collepardo-Guevara, Rosana
Dignon, Gregory L.
Dimova, Rumiana https://orcid.org/0000-0002-3872-8502
Elbaum-Garfinkle, Shana https://orcid.org/0000-0002-3953-7329
Fawzi, Nicolas L. https://orcid.org/0000-0001-5483-0577
Fuxreiter, Monika https://orcid.org/0000-0002-4463-6727
Gladfelter, Amy S. https://orcid.org/0000-0002-2490-6945
Honigmann, Alf https://orcid.org/0000-0003-0475-3790
Jain, Ankur https://orcid.org/0000-0002-0917-1602
Joseph, Jerelle A. https://orcid.org/0000-0003-4525-180X
Knowles, Tuomas P. J. https://orcid.org/0000-0002-7879-0140
Lasker, Keren https://orcid.org/0000-0002-5480-4173
Lemke, Edward A. https://orcid.org/0000-0002-0634-0503
Lindorff-Larsen, Kresten https://orcid.org/0000-0002-4750-6039
Lipowsky, Reinhard https://orcid.org/0000-0001-8417-8567
Mittal, Jeetain https://orcid.org/0000-0002-9725-6402
Mukhopadhyay, Samrat https://orcid.org/0000-0003-1242-9958
Myong, Sua https://orcid.org/0000-0001-9098-3423
Pappu, Rohit V. https://orcid.org/0000-0003-2568-1378
Rippe, Karsten https://orcid.org/0000-0001-9951-9395
Shelkovnikova, Tatyana A. https://orcid.org/0000-0003-1367-5309
Vecchiarelli, Anthony G. https://orcid.org/0000-0002-6198-3245
Wegmann, Susanne https://orcid.org/0000-0002-5388-2479
Zhang, Huaiying https://orcid.org/0000-0002-1784-2664
Zhang, Mingjie https://orcid.org/0000-0001-9404-0190
Zubieta, Chloe https://orcid.org/0000-0003-4558-9333
Zweckstetter, Markus https://orcid.org/0000-0002-2536-6581
Dormann, Dorothee https://orcid.org/0000-0002-9260-2775
Mittag, Tanja https://orcid.org/0000-0002-1827-3811
Article History
Received: 1 July 2025
Accepted: 7 July 2025
First Online: 19 August 2025
Competing interests
: S.A. is a scientific advisor and shareholder of Dewpoint Therapeutics. T.P.J.K. Is a co-founder of Transition Bio. K.L. is co-inventor on U.S. Patent Application US 2023/0044825 A1, which covers the use of protein condensates for synthetic applications. K.L.-L. holds stock options in and is a consultant for Peptone Ltd. R.V.P. is a member of the Scientific Advisory Board and shareholder in Dewpoint Therapeutics Inc. The remaining authors declare no competing interests.